VANGUARD GROUP INC

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol
KROS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
1,525,355 shares
Security Ownership %
5%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,525,355 shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS). This represents 5% ownership of the company. In their previous filing dated 30 Apr 2025, VANGUARD GROUP INC had reported owning 2,566,321 shares, indicating a decrease of +41%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.